We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
University of Cambridge Department of Pharmacology spin-out PolyProx Therapeutics has received £1m in seed capital from translation-focused medical research charity Life Arc.
University of Cambridge spin out PolyProx Therapeutics has announced it has raised £3.4m of seed capital, led by Cambridge Innovation Capital (CIC), RT Capital and Cambridge Enterprise.